Clustered O-Glycans of IgA1

IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world. Aberrantly glycosylated IgA1, with galactose (Gal)-deficient hinge region (HR) O-glycans, plays a pivotal role in the pathogenesis of the disease. It is not known whether the glycosylation defect occurs randomly or preferentially at specific sites. We have described the utility of activated ion-electron capture dissociation (AI-ECD) mass spectrometric analysis of IgA1 O-glycosylation. However, locating and characterizing the entire range of O-glycan attachment sites are analytically challenging due to the clustered serine and threonine residues in the HR of IgA1 heavy chain. To address this problem, we analyzed all glycoforms of the HR glycopeptides of a Gal-deficient IgA1 myeloma protein, mimicking the aberrant IgA1 in patients with IgAN, by use of a combination of IgA-specific proteases + trypsin and AI-ECD Fourier transform ion cyclotron resonance (FT-ICR) tandem mass spectrometry (MS/MS). The IgA-specific proteases provided a variety of IgA1 HR fragments that allowed unambiguous localization of all O-glycosylation sites in the six most abundant glycoforms, including the sites deficient in Gal. Additionally, this protocol was adapted for on-line liquid chromatography (LC)-AI-ECD MS/MS and LC-electron transfer dissociation MS/MS analysis. Our results thus represent a new clinically relevant approach that requires ECD/electron transfer dissociation-type fragmentation to define the molecular events leading to pathogenesis of a chronic kidney disease. Furthermore, this work offers generally applicable principles for the analysis of clustered sites of O-glycosylation.

[1]  P. Garred,et al.  Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[2]  M. J. Chalmers,et al.  Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy , 2007, Analytical and bioanalytical chemistry.

[3]  J. Barratt,et al.  Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. , 2001, Kidney international.

[4]  B. Julian,et al.  Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. , 1997, Kidney international.

[5]  Robert J Chalkley,et al.  Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides , 2009, Proceedings of the National Academy of Sciences.

[6]  M. J. Chalmers,et al.  Evaluation and optimization of electron capture dissociation efficiency in fourier transform ion cyclotron resonance mass spectrometry , 2005, Journal of the American Society for Mass Spectrometry.

[7]  A. G. Harrison,et al.  The gas‐phase basicities and proton affinities of amino acids and peptides , 1997 .

[8]  B. Julian,et al.  IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? , 1988, The American journal of medicine.

[9]  Yusuke Suzuki,et al.  Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. , 2009, The Journal of clinical investigation.

[10]  S. Mohammed,et al.  Effect of chemical modifications on peptide fragmentation behavior upon electron transfer induced dissociation. , 2009, Analytical chemistry.

[11]  E. Tarelli.  Resistance to deglycosylation by ammonia of IgA1 O-glycopeptides: implications for the beta-elimination of O-glycans linked to serine and threonine. , 2007, Carbohydrate research.

[12]  G. McAlister,et al.  Performance Characteristics of Electron Transfer Dissociation Mass Spectrometry*S , 2007, Molecular & Cellular Proteomics.

[13]  H. Cooper,et al.  Determination of Aberrant O-Glycosylation in the IgA1 Hinge Region by Electron Capture Dissociation Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry* , 2005, Journal of Biological Chemistry.

[14]  R. Dwek,et al.  Glycosylation and the immune system. , 2001, Science.

[15]  J. Novak,et al.  Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals , 2005, AIDS.

[16]  R. Dwek,et al.  Agalactosyl glycoforms of IgG autoantibodies are pathogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y. Hiki,et al.  Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. , 2000, Biochemical and biophysical research communications.

[18]  R. Zubarev,et al.  Localization of O-glycosylation sites in peptides by electron capture dissociation in a Fourier transform mass spectrometer. , 1999, Analytical chemistry.

[19]  Scott B Ficarro,et al.  Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. , 2007, Nature chemical biology.

[20]  E. Go,et al.  Label-free quantitation: A new glycoproteomics approach , 2009, Journal of the American Society for Mass Spectrometry.

[21]  E. Williams,et al.  Effects of charge state and cationizing agent on the electron capture dissociation of a peptide. , 2004, Analytical chemistry.

[22]  J. Brodbelt,et al.  Enhanced electron transfer dissociation through fixed charge derivatization of cysteines. , 2009, Analytical chemistry.

[23]  T. Noll,et al.  Localization of O-glycans in MUC1 glycoproteins using electron-capture dissociation fragmentation mass spectrometry. , 2009, Glycobiology.

[24]  H. Cooper,et al.  Liquid Chromatography Electron Capture Dissociation Tandem Mass Spectrometry (LC-ECD-MS/MS) versus Liquid Chromatography Collision-induced Dissociation Tandem Mass Spectrometry (LC-CID-MS/MS) for the Identification of Proteins , 2007, Journal of the American Society for Mass Spectrometry.

[25]  Y. Hiki,et al.  Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 1998, Journal of the American Society of Nephrology : JASN.

[26]  Jonathan C Trinidad,et al.  O-Linked N-Acetylglucosamine Proteomics of Postsynaptic Density Preparations Using Lectin Weak Affinity Chromatography and Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.

[27]  F. McLafferty,et al.  Activated ion electron capture dissociation for mass spectral sequencing of larger (42 kDa) proteins. , 2000, Analytical chemistry.

[28]  A G Marshall,et al.  Electron capture dissociation and infrared multiphoton dissociation MS/MS of an N-glycosylated tryptic peptic to yield complementary sequence information. , 2001, Analytical chemistry.

[29]  T. Irimura,et al.  The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation. , 2007, Glycobiology.

[30]  J. Novak,et al.  The Fap1 fimbrial adhesin is a glycoprotein: antibodies specific for the glycan moiety block the adhesion of Streptococcus parasanguis in an in vitro tooth model , 2002, Molecular microbiology.

[31]  F. Tureček,et al.  Host-guest hydrogen atom transfer induced by electron capture , 2009, Journal of the American Society for Mass Spectrometry.

[32]  G. Springer.  Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy , 1997, Journal of Molecular Medicine.

[33]  B. Julian,et al.  Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. , 1993, Contributions to nephrology.

[34]  R. Dwek,et al.  The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions* , 1998, The Journal of Biological Chemistry.

[35]  B. Julian,et al.  IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. , 2007, Contributions to nephrology.

[36]  Steven A Carr,et al.  Selective detection of glycopeptides on ion trap mass spectrometers. , 2004, Analytical chemistry.

[37]  B. Julian,et al.  Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. , 2007, Molecular immunology.

[38]  M. Tajiri,et al.  Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis. , 2010, Journal of proteome research.

[39]  G. Alarcón,et al.  IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. , 2008, The Journal of clinical investigation.

[40]  B. Julian,et al.  Progress in Molecular and Genetic Studies of IgA Nephropathy , 2001, Journal of Clinical Immunology.

[41]  O. Jensen,et al.  Peptide sequencing and characterization of post-translational modifications by enhanced ion-charging and liquid chromatography electron-transfer dissociation tandem mass spectrometry. , 2007, Analytical chemistry.

[42]  B. Julian,et al.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. , 1999, The Journal of clinical investigation.

[43]  Mohammad Mainul Islam,et al.  A Novel Branched-chain Amino Acid Metabolon , 2007, Journal of Biological Chemistry.

[44]  A. Vlad,et al.  MUC1 immunobiology: from discovery to clinical applications. , 2004, Advances in immunology.

[45]  Y. Hiki,et al.  Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. , 2001, Kidney international.

[46]  B. Julian,et al.  Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. , 2007, Kidney international.

[47]  A. L. Burlingame,et al.  Statistical analysis of Peptide electron transfer dissociation fragmentation mass spectrometry. , 2010, Analytical chemistry.

[48]  K. Medzihradszky,et al.  Affinity Enrichment and Characterization of Mucin Core-1 Type Glycopeptides from Bovine Serum* , 2009, Molecular & Cellular Proteomics.

[49]  J. Novak,et al.  Heterogeneity of O-glycosylation in the hinge region of human IgA1. , 2000, Molecular immunology.

[50]  R. Dwek,et al.  The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. , 2008, Glycobiology.

[51]  Z. Hao,et al.  On-line LC-MS approach combining collision-induced dissociation (CID), electron-transfer dissociation (ETD), and CID of an isolated charge-reduced species for the trace-level characterization of proteins with post-translational modifications. , 2007, Journal of proteome research.

[52]  Joshua J Coon,et al.  Infrared photoactivation reduces peptide folding and hydrogen-atom migration following ETD tandem mass spectrometry. , 2009, Angewandte Chemie.